Mark has a wealth of experience within the pharmaceutical and pharmaceutical services industries, including senior commercial roles with respected organisations such as Inceptua, Clinigen, Idis and Servier.

Prior to joining tranScrip, Mark was Chief Innovation Officer and Executive Board member at Resonant Group, a privately owned group of agencies, where he led the Origins business  while establishing a portfolio of potential value-enhancing opportunities.

Mark’s commercial and business leadership experience, will help tranScrip continue to develop and grow as a trusted partner for the pharmaceutical and biotech industry, and help make a real difference to the lives of patients.